表紙
市場調查報告書

全球感染疾病診斷市場:市場規模,市場佔有率,趨勢,預測

Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026

出版商 Coherent Market Insights 商品編碼 677999
出版日期 內容資訊 英文 171 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球感染疾病診斷市場:市場規模,市場佔有率,趨勢,預測 Infectious Disease Diagnostics Market - Size, Share, Trends, and Forecast to 2026
出版日期: 2018年07月18日內容資訊: 英文 171 Pages
簡介

本報告提供全球感染疾病診斷市場調查,市場概要,各產品類型、疾病、技術、檢驗地方、終端用戶、地區的市場規模的變化與預測,市場趨勢,成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概要

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 各產品類型
    • 各疾病
    • 各技術
    • 各檢驗地方
    • 各終端用戶
    • 各地區
  • 市場機會

第3章 市場趨勢,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • PEST分析
  • 波特的五力分析
  • 法規方案

第4章 全球感染疾病診斷市場:各產品類型

  • 簡介
  • 套件、試劑
  • 設備

第5章 全球性感染疾病診斷市場:各疾病

  • 簡介
  • HIV
  • 肝炎
  • 醫療相關感染(HAI)
  • 人類乳突病毒(HPV)
  • 結核
  • 流感
  • 其他

第6章 全球感染疾病診斷市場:各技術

  • 簡介
  • 免疫診斷藥
  • 聚合酵素鏈鎖反應(PCR)
  • 次世代定序(NGS)
  • 其他

第7章 全球感染疾病診斷市場:各檢驗地方

  • 簡介
  • 實驗室檢驗
  • POC檢驗

第8章 全球感染疾病診斷市場:各終端用戶

  • 簡介
  • 醫院
  • 病理/診斷中心
  • 研究機關
  • 居家照護
  • 其他

第9章 全球感染疾病診斷市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第10章 競爭情形

  • 公司概要
    • Danaher Corporation
    • Abbott Laboratories
    • Becton, Dickinson, and Company
    • F.Hoffmann La-Roche Ltd.
    • Trinity Biotech Plc
    • Cardinal Health, Inc.
    • BioMerieux
    • Bio-Rad Laboratories, Inc.
    • AccuBioTech Co., Ltd.
    • Acon Laboratories, Inc.

第11章 附錄

  • 參考文獻
  • 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Management of infectious diseases can be done with speedy diagnosis, implementation of preventive, and treatment strategies, and strict adherence to the treatment plan. Infectious diseases are lethal and may lead to death if not managed properly and in time. However, rapid and early diagnosis is the key in efficient management of the infectious diseases. Late diagnosis of the diseases often makes it difficult for proper management of the disease and to keep it from spreading.

As the prevalence of infectious diseases is increasing, the need of effective diagnostic tests is also increasing. Centralized laboratory testing has been the gold standard for disease diagnosis. However, emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic would be useful due to unavailability of labs, infrastructure, and trained personnel.

Market Dynamics

Technological advancements to facilitate speedy diagnosis and extensive product portfolios of infectious disease diagnostics offered by manufacturer’s supports the growth of infectious disease diagnostics market. Manufacturers are indulged in providing novel diagnostic solutions for identifying infectious diseases.

For instance, Becton Dickinson and Company launched first automated phenotypic test, BD Phoenix CPO detect test, to detect and classify carbapenemase-producing organisms (CPO) in 2017. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market.

Key features of the study:

This report provides in-depth analysis of infectious disease diagnostics market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and Acon Laboratories, Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the infectious disease diagnostics market

Detailed Segmentation:

  • Global Infectious Disease Diagnostics Market, By Product Type:
  • Kits & Reagents
  • Instruments
  • Global Infectious Disease Diagnostics Market, By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • Global Infectious Disease Diagnostics Market, By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • Global Infectious Disease Diagnostics Market, By Test Location:
  • Laboratory Testing
  • Point-of-Care Testing
  • Global Infectious Disease Diagnostics Market, By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • Global Infectious Disease Diagnostics Market, By Geography:
  • North America
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product:
  • Kits & Reagents
  • Instruments
  • By Disease Type:
  • HIV
  • Hepatitis
  • Healthcare Associated Infections (HAIs)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Others
  • By Technology:
  • Immunodiagnostics
  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Others
  • By Test Location
  • Laboratory Testing
  • Point-of-Care Testing
  • By End User:
  • Hospitals
  • Pathology/Diagnostic Laboratories
  • Research Institutes
  • Home-Care Settings
  • Others
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Danaher Corporation*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • Hoffmann La-Roche Ltd.
  • Trinity Biotech Plc
  • Cardinal Health, Inc.
  • BioMérieux
  • Bio-Rad Laboratories, Inc.
  • AccuBioTech Co., Ltd.
  • Acon Laboratories, Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Disease Type
    • Market Snippet, By Technology
    • Market Snippet, By Test Location
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PEST Analysis
  • PORTER's Analysis
  • Regulatory Scenario

4. Global Infectious Disease Diagnostics Market, By Product Type, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Infectious Disease Diagnostics Market, By Disease Type, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • HIV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Hepatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Healthcare Associated Infections (HAIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Human Papillomavirus (HPV)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Tuberculosis (TB)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Infectious Disease Diagnostics Market, By Technology, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Immunodiagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Next Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Infectious Disease Diagnostics Market, By Test Location, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Laboratory Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Point of Care Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Infectious Disease Diagnostics Market, By End User, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2016 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Pathology/Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Home-Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

9. Global Infectious Disease Diagnostics Market, By Region, 2016 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Disease Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Test Location, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

10. Competitive Landscape

  • Company Profiles
    • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Becton, Dickinson, and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • F.Hoffmann La-Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Trinity Biotech Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cardinal Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BioMerieux
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AccuBioTech Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Acon Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top